氟达拉滨治疗慢性淋巴细胞白血病后发生的肿瘤溶解综合征
Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.
作者信息
Montalban C, Liaño F, Aguilera A
机构信息
Department of Internal Medicine, Hospital Ramón y Cajal, Universidad de Alcalá de Henares, Madrid, Spain.
出版信息
Postgrad Med J. 1994 Sep;70(827):651-2. doi: 10.1136/pgmj.70.827.651.
Abstract
Fludarabine is one of the most recent and promising therapeutic agents for chronic lymphocytic leukaemia. We describe a patient who developed tumour lysis syndrome after the first course of treatment with fludarabine and call attention to this uncommon but potentially lethal complication that has not been previously taken into account in this neoplasia. It should always be anticipated when patients are treated with new and effective drugs.
摘要
氟达拉滨是治疗慢性淋巴细胞白血病的最新且最有前景的治疗药物之一。我们描述了一名患者，其在接受首个疗程的氟达拉滨治疗后发生了肿瘤溶解综合征，并提醒注意这种在该肿瘤中未被先前考虑到的罕见但可能致命的并发症。在使用新的有效药物治疗患者时应始终对此有所预见。
相似文献
1
Tumour lysis syndrome after treatment of chronic lymphocytic leukaemia with fludarabine.氟达拉滨治疗慢性淋巴细胞白血病后发生的肿瘤溶解综合征
Postgrad Med J. 1994 Sep;70(827):651-2. doi: 10.1136/pgmj.70.827.651.
2
Fludarabine causing tumour lysis syndrome in chronic lymphocytic leukaemia.氟达拉滨引发慢性淋巴细胞白血病的肿瘤溶解综合征。
Aust N Z J Med. 1994 Aug;24(4):406-7. doi: 10.1111/j.1445-5994.1994.tb01473.x.
3
Acute tumour lysis syndrome after oral fludarabine in a patient with chronic lymphocytic leukaemia.一名慢性淋巴细胞白血病患者口服氟达拉滨后发生急性肿瘤溶解综合征。
Hematol J. 2004;5(6):528-9. doi: 10.1038/sj.thj.6200409.
4
Tumor lysis syndrome associated with fludarabine treatment in chronic lymphocytic leukemia.慢性淋巴细胞白血病中与氟达拉滨治疗相关的肿瘤溶解综合征
Ann Pharmacother. 2004 Jul-Aug;38(7-8):1319-20. doi: 10.1345/aph.1D538. Epub 2004 May 11.
5
Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.氟达拉滨与慢性淋巴细胞白血病中的急性肿瘤溶解
N Engl J Med. 1992 Nov 5;327(19):1396-7. doi: 10.1056/NEJM199211053271921.
6
Acute tumor lysis syndrome during oral fludarabine treatment for CLL--a rare event that might be observed more frequently in the future.口服氟达拉滨治疗慢性淋巴细胞白血病期间发生急性肿瘤溶解综合征——这是一种罕见事件，未来可能会更频繁地被观察到。
Onkologie. 2008 Apr;31(4):157-8. doi: 10.1159/000120154. Epub 2008 Mar 20.
7
Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.肿瘤溶解综合征：氟达拉滨治疗慢性淋巴细胞白血病的一种罕见并发症。
J Clin Oncol. 1998 Jul;16(7):2313-20. doi: 10.1200/JCO.1998.16.7.2313.
8
Acute tumor lysis syndrome during oral fludarabine treatment for chronic lymphocytic leukemia. Role of treatment with rasburicase.口服氟达拉滨治疗慢性淋巴细胞白血病期间的急性肿瘤溶解综合征。重组尿酸氧化酶治疗的作用。
Onkologie. 2008 Apr;31(4):197-9. doi: 10.1159/000118524. Epub 2008 Mar 20.
9
Tumor lysis syndrome (TLS) following fludarabine therapy for chronic lymphocytic leukemia (CLL): case report and review of the literature.氟达拉滨治疗慢性淋巴细胞白血病（CLL）后发生的肿瘤溶解综合征（TLS）：病例报告及文献复习
Am J Hematol. 2003 Mar;72(3):212-5. doi: 10.1002/ajh.10283.
10
Acute tumor lysis syndrome complicating fludarabine treatment of prolymphocytic leukemia.急性肿瘤溶解综合征并发氟达拉滨治疗幼淋巴细胞白血病
Conn Med. 1993 Oct;57(10):651-4.
引用本文的文献
1
Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.氟达拉滨。其药理学及在血液系统恶性肿瘤治疗中应用的最新进展。
Drugs. 1997 Jun;53(6):1005-37. doi: 10.2165/00003495-199753060-00007.
本文引用的文献
1
Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia.氟达拉滨在难治性慢性淋巴细胞白血病中的免疫抑制作用及临床反应
Ann Oncol. 1993 May;4(5):371-5. doi: 10.1093/oxfordjournals.annonc.a058515.
2
Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.氟达拉滨。其药理特性及在恶性肿瘤治疗中的潜力综述。
Drugs. 1993 May;45(5):737-59. doi: 10.2165/00003495-199345050-00009.
3
4
Acute tumor lysis syndrome in prolymphocytic leukemia.幼淋巴细胞白血病中的急性肿瘤溶解综合征
Arch Intern Med. 1987 Feb;147(2):375-6.
5
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
Blood. 1989 Jul;74(1):19-25.
6
Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide.
Cancer. 1990 Jul 15;66(2):246-50. doi: 10.1002/1097-0142(19900715)66:2<246::aid-cncr2820660209>3.0.co;2-b.
7
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
J Clin Oncol. 1991 Jan;9(1):44-9. doi: 10.1200/JCO.1991.9.1.44.
8
Tumor lysis syndrome complicating treatment of chronic lymphocytic leukemia with fludarabine phosphate.
Am J Med. 1990 Sep;89(3):388-90. doi: 10.1016/0002-9343(90)90358-k.
9
Fludarabine and acute tumor lysis in chronic lymphocytic leukemia.氟达拉滨与慢性淋巴细胞白血病中的急性肿瘤溶解
N Engl J Med. 1992 Nov 5;327(19):1396-7. doi: 10.1056/NEJM199211053271921.
10
Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.
J Clin Oncol. 1992 May;10(5):790-4. doi: 10.1200/JCO.1992.10.5.790.
Zotero 插件